Barclays’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.06M Buy
168,014
+15,497
+10% +$190K ﹤0.01% 2209
2025
Q1
$3.35M Sell
152,517
-32,507
-18% -$714K ﹤0.01% 1687
2024
Q4
$4.2M Buy
185,024
+121
+0.1% +$2.74K ﹤0.01% 1729
2024
Q3
$3.36M Buy
184,903
+159,736
+635% +$2.9M ﹤0.01% 1810
2024
Q2
$733K Sell
25,167
-49,076
-66% -$1.43M ﹤0.01% 2295
2024
Q1
$2.63M Buy
74,243
+8,438
+13% +$299K ﹤0.01% 1754
2023
Q4
$2.87M Buy
65,805
+24,327
+59% +$1.06M ﹤0.01% 1915
2023
Q3
$1.58M Sell
41,478
-13,370
-24% -$510K ﹤0.01% 1798
2023
Q2
$2.26M Buy
54,848
+20,551
+60% +$846K ﹤0.01% 1674
2023
Q1
$1.97M Sell
34,297
-73,948
-68% -$4.24M ﹤0.01% 1665
2022
Q4
$6.07M Buy
108,245
+47,418
+78% +$2.66M ﹤0.01% 1012
2022
Q3
$2.58M Buy
60,827
+20,139
+49% +$854K ﹤0.01% 1485
2022
Q2
$2.2M Buy
40,688
+11,763
+41% +$635K ﹤0.01% 1537
2022
Q1
$1.86M Buy
28,925
+9,040
+45% +$580K ﹤0.01% 1831
2021
Q4
$1.33M Sell
19,885
-25,644
-56% -$1.72M ﹤0.01% 2032
2021
Q3
$3.12M Sell
45,529
-9,729
-18% -$666K ﹤0.01% 1554
2021
Q2
$3.77M Buy
55,258
+16,666
+43% +$1.14M ﹤0.01% 1350
2021
Q1
$2.67M Sell
38,592
-8,235
-18% -$569K ﹤0.01% 1655
2020
Q4
$3.04M Sell
46,827
-13,850
-23% -$899K ﹤0.01% 1321
2020
Q3
$2.87M Sell
60,677
-9,596
-14% -$453K ﹤0.01% 1279
2020
Q2
$3.3M Buy
70,273
+17,722
+34% +$833K ﹤0.01% 1156
2020
Q1
$2.35M Buy
52,551
+44,796
+578% +$2M ﹤0.01% 1260
2019
Q4
$451K Buy
7,755
+4,406
+132% +$256K ﹤0.01% 2746
2019
Q3
$201K Sell
3,349
-78,956
-96% -$4.74M ﹤0.01% 3055
2019
Q2
$4.6M Buy
82,305
+55,896
+212% +$3.12M ﹤0.01% 1143
2019
Q1
$1.47M Sell
26,409
-16,318
-38% -$910K ﹤0.01% 1827
2018
Q4
$1.93M Buy
42,727
+13,621
+47% +$615K ﹤0.01% 1382
2018
Q3
$1.92M Sell
29,106
-64,147
-69% -$4.22M ﹤0.01% 1813
2018
Q2
$6.01M Buy
93,253
+73,684
+377% +$4.75M 0.01% 924
2018
Q1
$1.08M Buy
19,569
+9,476
+94% +$524K ﹤0.01% 1746
2017
Q4
$483K Sell
10,093
-10,698
-51% -$512K ﹤0.01% 2108
2017
Q3
$1.05M Buy
20,791
+13,600
+189% +$686K ﹤0.01% 1555
2017
Q2
$392K Buy
7,191
+3,145
+78% +$171K ﹤0.01% 2051
2017
Q1
$170K Sell
4,046
-89,018
-96% -$3.74M ﹤0.01% 2590
2016
Q4
$3.99M Buy
93,064
+47,120
+103% +$2.02M ﹤0.01% 844
2016
Q3
$1.9M Buy
45,944
+43,156
+1,548% +$1.78M ﹤0.01% 1105
2016
Q2
$111K Buy
2,788
+2,714
+3,668% +$108K ﹤0.01% 2306
2016
Q1
$2K Buy
+74
New +$2K ﹤0.01% 3207
2015
Q4
Sell
-296
Closed -$9K 3435
2015
Q3
$9K Sell
296
-900
-75% -$27.4K ﹤0.01% 3100
2015
Q2
$32K Sell
1,196
-641
-35% -$17.2K ﹤0.01% 2792
2015
Q1
$45K Sell
1,837
-3,110
-63% -$76.2K ﹤0.01% 2789
2014
Q4
$109K Buy
4,947
+1,346
+37% +$29.7K ﹤0.01% 2661
2014
Q3
$72K Buy
3,601
+2,490
+224% +$49.8K ﹤0.01% 2800
2014
Q2
$21K Sell
1,111
-1,186
-52% -$22.4K ﹤0.01% 3392
2014
Q1
$42K Sell
2,297
-48,103
-95% -$880K ﹤0.01% 3250
2013
Q4
$968K Buy
50,400
+6,376
+14% +$122K ﹤0.01% 1791
2013
Q3
$720K Sell
44,024
-4,671
-10% -$76.4K ﹤0.01% 1895
2013
Q2
$729K Buy
+48,695
New +$729K ﹤0.01% 1975